Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells.
about
Vaccination in the elderlyImmunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse modelsRegulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbetaAn enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.DNA vaccines for cervical cancerPhase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesisIn vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virusTherapeutic HPV DNA vaccines.Perspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialDepletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory.Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protectionTherapeutic Vaccine Strategies against Human Papillomavirus.HPV infection: immunological aspects and their utility in future therapyVirus-like particles for the prevention of human papillomavirus-associated malignancies.Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?Current state in the development of candidate therapeutic HPV vaccinesTherapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.Therapeutic vaccines for high-risk HPV-associated diseases.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
P2860
Q27022304-7586DA66-922C-45EB-8999-6ABC5E3BFC08Q28083154-CEC26556-155B-4CEA-86E5-FA94C771FEBBQ28475223-241456F9-448E-42D4-A573-13EE70F814B0Q31121276-196FF7B8-6E03-4685-989A-61CA56187C67Q33680693-789A6C7F-5A7A-4A7D-9C48-C5886E5A55CDQ33783092-C3D9920F-936C-4CD9-84ED-3573A1B04B3FQ33833910-4A464034-0D91-4545-A3F1-CBA258DA0B48Q33889113-8087C675-B13F-4311-A106-37231EFFA35BQ33936427-312BE8F4-EED1-4031-8A69-2B9A84B6B217Q34011494-A286B25D-84D3-437B-A35F-9284FCCD3869Q34033763-84BEBCB2-C09D-4922-ACF9-1309FA103DEFQ34035169-80A667B0-37A2-439F-A695-8A461346A2FBQ34339707-71CE0157-B228-476A-AF0F-B8B302349A9EQ35826752-9F14D787-E4EF-457F-8339-9B61BEC406CDQ37145093-6FD7B3A6-4299-4DDF-8F5F-0B270BC3E92EQ37328475-20EB5F1A-65EA-4199-81F1-E69EB19B6AC0Q37943790-5A28C5B8-24AD-4B02-AEDC-99EDAB3C8A6DQ38743922-BB18A8AF-185F-4C4E-AE19-143B5312783EQ46248185-348CA5FE-75F3-492A-AE8A-1987D4066753Q47255618-0551EAC8-DB20-449A-91D4-E405A9B4A1F0Q50115667-F236C528-4EEA-4EBA-B4B4-0C8BCD0F602F
P2860
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@en
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@nl
type
label
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@en
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@nl
prefLabel
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@en
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@nl
P2093
P2860
P1433
P1476
Enhancing therapeutic HPV DNA ...... CD4+CD25+ T regulatory cells.
@en
P2093
Archana Monie
Chi-Mu Chuang
Chien-Fu Hung
Mei-Cheng Wang
Talia Hoory
P2860
P304
P356
10.1016/J.VACCINE.2008.11.042
P407
P577
2008-12-03T00:00:00Z